.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
QuintilesIMS
Novartis
Dow
Deloitte
Cantor Fitzgerald
Medtronic
Cerilliant
Covington
Merck

Generated: December 17, 2017

DrugPatentWatch Database Preview

ATOVAQUONE Drug Profile

« Back to Dashboard

When do Atovaquone patents expire, and what generic alternatives are available?

Atovaquone is a drug marketed by Amneal Pharms, Apotex Inc, Paddock Llc, Glenmark Generics, and Mylan Pharms Inc. and is included in five NDAs.

The generic ingredient in ATOVAQUONE is atovaquone; proguanil hydrochloride. There are sixteen drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the atovaquone; proguanil hydrochloride profile page.
Drug patent expirations by year for ATOVAQUONE

Pharmacology for ATOVAQUONE

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amneal PharmsATOVAQUONEatovaquoneSUSPENSION;ORAL202960-001Mar 18, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan Pharms IncATOVAQUONE AND PROGUANIL HYDROCHLORIDEatovaquone; proguanil hydrochlorideTABLET;ORAL202362-002May 27, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Glenmark GenericsATOVAQUONE AND PROGUANIL HYDROCHLORIDEatovaquone; proguanil hydrochlorideTABLET;ORAL091211-002Apr 6, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Apotex IncATOVAQUONEatovaquoneSUSPENSION;ORAL209750-001Oct 11, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Paddock LlcATOVAQUONEatovaquoneSUSPENSION;ORAL207833-001Apr 28, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan Pharms IncATOVAQUONE AND PROGUANIL HYDROCHLORIDEatovaquone; proguanil hydrochlorideTABLET;ORAL202362-001May 27, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Glenmark GenericsATOVAQUONE AND PROGUANIL HYDROCHLORIDEatovaquone; proguanil hydrochlorideTABLET;ORAL091211-001Jan 12, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
McKesson
Argus Health
Express Scripts
Julphar
US Army
Fish and Richardson
McKinsey
QuintilesIMS
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot